“Novel substituted 5-arylidene-1, 3-thiazolidin-4-one analogues: Synthesis, optimization, anticancer screening and docking studies”, Journal of Pharmaceutical Negative Results, pp. 2378–2389, Oct. 2022, doi: 10.47750/pnr.2022.13.S06.310.